RKDA - Arcadia Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,4644,0263,1885,414
Cost of Revenue6,7307,6909,5589,858
Gross Profit-5,266-3,664-6,370-4,444
Operating Expenses
Research Development----
Selling General and Administrative11,60410,65111,05011,119
Non Recurring----
Total Operating Expenses18,33418,34120,60820,977
Operating Income or Loss-16,870-14,315-17,420-15,563
Income from Continuing Operations
Total Other Income/Expenses Net3,400-1,366-2,179-2,367
Earnings Before Interest and Taxes-16,870-14,315-17,420-15,563
Interest Expense--747-1,319-2,658
Income Before Tax-13,470-15,681-19,599-17,930
Income Tax Expense10262526
Minority Interest----
Net Income From Continuing Ops-13,480-15,707-19,624-17,956
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-13,480-15,707-19,624-17,956
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-13,480-15,707-19,624-20,727